PharmaCorp Rx Inc
XTSX:PCRX
PharmaCorp Rx Inc
XTSX:PCRX
Price:
0.415
CAD
-1.19%
Market Closed
Market Cap:
CA$72.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PharmaCorp Rx Inc
XTSX:PCRX
|
CA |
|
Bank of N T Butterfield & Son Ltd
NYSE:NTB
|
BM |
|
ASA International Group PLC
LSE:ASAI
|
NL |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
IN |
|
G
|
Genetec Technology Bhd
KLSE:GENETEC
|
MY |
|
Suryamas Dutamakmur Tbk PT
IDX:SMDM
|
ID |
|
Nandani Creation Ltd
NSE:JAIPURKURT
|
IN |
|
Times China Holdings Ltd
HKEX:1233
|
CN |
|
A
|
AUX International Holdings Ltd
HKEX:2080
|
HK |
|
H
|
Hoang Quan Consulting Trading Service Real Estate Corp
VN:HQC
|
VN |
|
M
|
M4B SA
WSE:M4B
|
PL |
|
LS Electric Co Ltd
KRX:010120
|
KR |
|
DEPPON LOGISTICS Co Ltd
SSE:603056
|
CN |
Balance Sheet
Balance Sheet Decomposition
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Balance Sheet Decomposition is not available for
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Balance Sheet
PharmaCorp Rx Inc
PharmaCorp Rx Inc
Currency: CAD
| Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
1
|
3
|
2
|
13
|
|
| Cash Equivalents |
1
|
3
|
2
|
13
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
3
|
2
|
15
|
|
| PP&E Net |
0
|
0
|
0
|
4
|
|
| PP&E Gross |
0
|
0
|
0
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
5
|
|
| Goodwill |
0
|
0
|
0
|
11
|
|
| Other Assets |
0
|
0
|
0
|
11
|
|
| Total Assets |
1
N/A
|
3
+173%
|
2
-15%
|
35
+1 417%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
0
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-37%
|
0
+180%
|
5
+10 431%
|
|
| Equity | |||||
| Common Stock |
1
|
3
|
3
|
32
|
|
| Retained Earnings |
0
|
1
|
1
|
2
|
|
| Additional Paid In Capital |
0
|
1
|
0
|
1
|
|
| Total Equity |
1
N/A
|
3
+179%
|
2
-16%
|
30
+1 234%
|
|
| Total Liabilities & Equity |
1
N/A
|
3
+173%
|
2
-15%
|
35
+1 417%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
40
|
40
|
40
|
117
|
|
Switch to:
Switch to:
See Also
Discover More
